Product Information
MISOPROSTOL 100 MCG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4645 per EA under NDC 59762500701. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 27, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 ug/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762500701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MISOPROSTOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA019268FDA Approved
12/27/1988
TE Code
AB
On Market Since
12/27/2009
Pharmacological Classes
Price Statistics
The NADAC for MISOPROSTOL 100 MCG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4645 per EA |
|---|---|
| All-time high | $0.5875 (Jul 12, 2023) |
| All-time low | $0.3716 (Jun 23, 2021) |
| 52-week high | $0.4842 |
| 52-week low | $0.4243 |
| Median price | $0.4453 |
| Average price | $0.4551 |
| Largest weekly change | +48.4% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MISOPROSTOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin E1 Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MISOPROSTOL 100 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MISOPROSTOL 100 MCG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.4645 per EA (NDC 59762500701), effective Sep 30, 2026.
How has the price of MISOPROSTOL 100 MCG TABLET changed over time?
Over the history we have for it, the NADAC for MISOPROSTOL 100 MCG TABLET has risen 5.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MISOPROSTOL 100 MCG TABLET?
Since Nov 28, 2013, the NADAC for MISOPROSTOL 100 MCG TABLET has ranged from a low of $0.3716 (Jun 23, 2021) to a high of $0.5875 (Jul 12, 2023), with a median of $0.4453 per EA.
Are there cheaper alternatives to MISOPROSTOL 100 MCG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MISOPROSTOL 100 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MISOPROSTOL 100 MCG TABLET?
MISOPROSTOL 100 MCG TABLET (NDC 59762500701) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.